Download PDF
1 / Pages

Other users also viewed these articles

Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease Toshiya Machida; Taku Obara; Makoto Miyazaki; Jun Inoue; Nariyasu Mano;
10.1016/j.aohep.2022.100699
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study Stefano Gitto; Paolo Magistri; Luca Marzi; Nicolò Mannelli; Nicola De Maria; Andrea Mega; Giovanni Vitale; Giovanna Valente; Francesco Vizzutti; Erica Villa; Fabio Marra; Pietro Andreone; Margherita Falcini; Barbara Catellani; Gian Piero Guerrini; Valentina Serra; Stefano Di Sandro; Roberto Ballarin; Guido Piai; Filippo Schepis; Marzia Margotti; Carmela Cursaro; Paolo De Simone; Stefania Petruccelli; Paola Carrai; Paolo Forte; Claudia Campani; Heinz Zoller; Fabrizio Di Benedetto;
10.1016/j.aohep.2022.100683
Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors Kentaro Horiuchi; Tomomi Kogiso; Takaomi Sagawa; Makiko Taniai; Yoshito Kotera; Hiroto Egawa; Katsutoshi Tokushige;
10.1016/j.aohep.2022.100670